Concepedia
Statistics
Publications
16
Citations
1K
H-Index
14
Active since
1998
Affiliations
Bayer (Germany)(Current)
Bayer (United States)
Charité - Universitätsmedizin Berlin
University College London
Bayer (Italy)
Marius Giurescu is an author at Bayer (Germany) specializing in medicine, cancer pharmacology, and pharmacology.
Publications per year
1998–2017
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Martin Dreyling, Armando Santoro, Luigina Mollica et al. · Journal of Clinical Oncology · 2017 · 398 citations
Medicine, Oncology, Pharmacology +13
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma
M. Dreyling, Franck Morschhauser, Krimo Bouabdallah et al. · Annals of Oncology · 2017 · 272 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +11
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
Jean‐Luc Van Laethem, Hanno Riess, Jacek Jassem et al. · Targeted Oncology · 2016 · 61 citations
Medicine, Oncology, Pharmacology +10
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
Peter Schmid, Philipp Kiewe, K. Possinger et al. · Annals of Oncology · 2009 · 42 citations · Full text
A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors
Peter Schmid, Philipp Kiewe, Dagmar Kuehnhardt et al. · Journal of Clinical Oncology · 2005 · 38 citations
Medicine, Oncology, Pharmacology +15
1–5 of 16